Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, an artificial intelligence and machine learning drug discovery platform developed by Eli Lilly and Company.

• Technical Integration: Axcelead DDP will contribute proprietary drug discovery data to TuneLab to help improve predictive models for small molecules and antibody therapeutics, including ADME, safety and preclinical attributes.
• Operational Framework: TuneLab uses federated learning to improve predictive models while allowing participating organisations to retain control of their proprietary data.
• Participant Status: Axcelead DDP is the first contract research organisation to participate in TuneLab under this collaborative model and will be able to utilise TuneLab models when supporting biotechnology customers.

This summary is based on a news report published by BioSpectrum Asia.

Image for illustrative purposes only. Source: Canva.

About Ehub365

For Corporate Clients, ehub365 division delivers critical insights into the ASEAN medical sector, covering investments, new services, and practitioner news. 

A member of 365Asia. Our additional group services are Health365, 365Asia, 健康365, 365Sehat, and 365MEC.